XML 51 R39.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The following table summarizes the impact of all stock-based compensation expense on our Consolidated Statements of Loss for the years ended December 31, 2024, 2023 and 2022:

 

(in millions)

 

2024

 

 

2023

 

 

2022

 

Selling, general and administrative expense

 

$

11.9

 

 

$

14.8

 

 

$

9.5

 

(Loss) income before income tax

 

 

(11.9

)

 

 

(14.8

)

 

 

(9.5

)

Income tax expense

 

 

(2.9

)

 

 

(3.4

)

 

 

(2.2

)

Net loss

 

$

(9.0

)

 

$

(11.4

)

 

$

(7.3

)

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan

Stock-based compensation expense by award type for the years ended December 31, 2024, 2023 and 2022 was as follows:

 

(in millions)

 

2024

 

 

2023

 

 

2022

 

Stock option compensation expense

 

$

0.5

 

 

$

2.7

 

 

$

3.7

 

RSU compensation expense

 

 

7.5

 

 

 

6.4

 

 

 

4.4

 

PSU compensation expense

 

 

3.9

 

 

 

5.7

 

 

 

1.4

 

Total stock-based compensation expense

 

$

11.9

 

 

$

14.8

 

 

$

9.5

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model and the weighted average assumptions as outlined in the following table:

 

 

 

Year Ended December 31,

 

 

2022

Weighted average expected lives

 

6.0 years

Weighted average risk-free interest rate

 

1.89 %

Weighted average expected volatility

 

41.7 %

Expected dividend yield

 

3.60 %

Weighted average grant date fair value

 

$2.43

Summary of Changes in Stock Options Outstanding

A summary of the changes in stock options outstanding under the Plan during the year ended December 31, 2024 is presented below:

 

 

 

Number
Outstanding

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term

 

Aggregate
Intrinsic
Value

Outstanding at December 31, 2023

 

 

6,625,226

 

 

$

9.26

 

 

 

 

 

Forfeited/Expired

 

 

(913,930

)

 

$

11.27

 

 

 

 

 

Outstanding at December 31, 2024

 

 

5,711,296

 

 

$

8.94

 

 

4.7 years

 

zero

Exercisable shares at December 31, 2024

 

 

5,212,811

 

 

 

 

 

4.5 years

 

zero

Summary of Changes in RSUs Outstanding

A summary of the changes in the RSUs outstanding under the Plan during 2024 is presented below:

 

 

 

Stock
Units

 

 

Weighted Average Grant Date Fair Value

 

Outstanding at December 31, 2023

 

 

3,444,450

 

 

$

6.63

 

Granted

 

 

1,501,759

 

 

$

5.31

 

Vested and distributed

 

 

(253,634

)

 

$

8.43

 

Vested and deferred distributed

 

 

(133,273

)

 

$

7.71

 

Forfeited and cancelled

 

 

(317,413

)

 

$

6.09

 

Outstanding at December 31, 2024

 

 

4,241,889

 

 

$

6.06

 

Vested and deferred at December 31, 2024(1)

 

 

767,216

 

 

$

7.80

 

 

(1)
Included in outstanding at December 31, 2024. Vested and deferred RSUs are primarily related to deferred compensation for non-employee directors.
Summary of Changes in PSUs Outstanding

A summary of the changes in the PSUs outstanding under the Plan during 2024 is presented below:

 

 

 

Stock
Units

 

 

Weighted Average Grant Date Fair Value

 

Outstanding at December 31, 2023

 

 

1,771,690

 

 

$

6.48

 

Granted

 

 

1,825,683

 

 

$

5.80

 

Vested and distributed

 

 

(685,998

)

 

$

6.74

 

Forfeited and cancelled

 

 

(319,295

)

 

$

5.65

 

Other - increase due to performance of PSUs

 

 

954,162

 

 

$

5.21

 

Outstanding at December 31, 2024

 

 

3,546,242

 

 

$

5.81